Dr KAN Junsuo| kanjs@pathology.hku.hk
PhD HK
Research Interest
To tackle cancer by unfolding the epigenetic code of cancer stem cells.
Modern cancer research has pinpointed a small subpopulation of bulky cancer, termed cancer stem cells or tumor initiating cells as promising targets for cancer cure. The separation and termination of this population rely on identification of stem cell markers. As certain molecules have emerged in the scenario, I’m intrigued to study their epigenetic regulation to chase the elusive ‘stemness’.
Recent Publication Lists
Junsuo Kan, Lan Zou, Jingjing Zhang, Rentian Wu, Ziyi Wang, and Chun Liang. ORC Mediates Histone 3 LYSINE 4 Methylation through Cooperation with Spp1 in Saccharomyces cerevisiae (2008) J Biol Chem. 2008 Dec 5;283(49):33803-7
Wenbi Wu, Hanquan Liang, Junsuo Kan, Chao Liu, Meijin Yuan, Chun Liang, Kai Yang*,and Yi Pang. (2008) Autographa californica Multiple Nucleopolyhedrovirus 38K Is a Novel Nucleocapsid Protein That Interacts with VP1054, VP39, VP80 and Itself. J. Virol. doi:10.1128/JVI.00948-08 J Virol. 2008 Dec;82(24):12356-64
Junsuo Kan, Ziyi Wang, Shaoke Lou, Zhen Tu, Xing Wu, and Chun Liang. A GROUP OF GENERAL REPLICATORS AND REPLICATION ORIGINS DISTRIBUTED THROUGHOUT THE HUMAN GENOME (2007) Eukaryotic DNA Replication and Genome Maintenance. Cold Spring Harbor Laboratory